<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00106080</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 02-292</org_study_id>
    <nct_id>NCT00106080</nct_id>
  </id_info>
  <brief_title>Improving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <official_title>Improving the Quality of End-of-Life Communication for Patients With COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate a multifaceted intervention to improve the quality
      of end-of-life communication between patients with COPD and their primary care providers
      using information about patients preferences for end of life care and how to communicate and
      use this information to activate patients, family members, and healthcare providers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project builds on previous work that described preferences important to patients at
      end-of-life and desire for life-sustaining therapy by incorporating these attributes into a
      multifaceted intervention designed to improve the quality of end-of-life communication.

      Our specific aim was to evaluate a multifaceted intervention to improve the quality of
      end-of-life communication between patients with moderate or severe COPD and their primary
      care providers. The intervention is based on self-efficacy theory and includes provider
      education, local champions and role models, determination of patients individual barriers and
      facilitators regarding communication about end-of-life care, preferences for communication
      about end-of-life care and preferences for end-of-life care and using this information to
      activate patients, family members, and healthcare providers.

      For both control and intervention patients we collected the following information which was
      incorporated into a one-page summary report:

        1. Preferences about cardiopulmonary resuscitation (CPR) and mechanical ventilation

        2. Preferences for communication with provider

        3. Measure of severity of airflow obstruction

        4. Barriers and facilitators to communication

        5. Preferences for end-of-life care

      The intervention was incorporated into a usual clinic visit. For the upcoming clinic visit,
      we generated an individualized one-page patient specific feedback form for intervention group
      patients and providers. Patients and providers in the control group did not receive the form.

      The generated one-page feedback form was:

        1. Mailed to the patient to share with their surrogate

        2. Sent to their provider prior to the clinic visit

        3. Provided to the patient prior to their clinic visit

      The methods used for this study could be translated into clinic practice and possibly
      generalized to other chronic life-threatening conditions.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of Intervention on Quality of Patient Clinician Communication About End-of-Life Care(QOC) Scale</measure>
    <time_frame>Measured at enrollment and 2 weeks after targeted clinic visit</time_frame>
    <description>The quality of end-of-life communication (QOC) score ranges between 0 and 100, with higher scores indicating better communication between patients and providers.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of Intervention on Patient Reported Discussions About Treatment Preferences at Their Last Clinic Visit.</measure>
    <time_frame>Assessed 2 weeks after targeted clinic visit</time_frame>
    <description>We measured the difference between intervention and control group patients reporting having had a discussion with their clinician about treatment preferences at their last clinic visit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">376</enrollment>
  <condition>Pulmonary Disease</condition>
  <condition>COPD</condition>
  <condition>Chronic Bronchitis</condition>
  <condition>Emphysema</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Audit and Feedback</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Audit and Feedback</intervention_name>
    <description>Intervention patients and clinicians received a one-page patient-specific individualized summary, based on questionnaire responses, to stimulate conversations.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        One or more of the following:

        1 Have 3 or more outpatient clinics visits for COPD (ICD-9) in the two years prior to
        enrollment.

        2. Have been hospitalized with a primary discharge diagnosis (ICD-9) for COPD in the two
        years prior to enrollment.

        3. Active use of inhaled beta-agonist and ipratropium bromide (or equivalent in combination
        inhalers like Combivent) in the 12 months prior to enrollment.

        Plus

          1. Have a future visit scheduled in one of the eligible primary care or chest clinics;
             and

          2. Have airflow limitation

        Exclusion Criteria:

          1. If they have cognitive dysfunction, language barriers or severe psychiatric disorder
             that would preclude them from completing the questionnaires. This was assessed
             initially by the patients provider and by the research assistant during in-person
             interviews.

          2. The provider taking care of their COPD does not participate.

          3. Have a new diagnosis of COPD within the last month.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David H Au, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Puget Sound Health Care System Seattle Division, Seattle, WA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System Seattle Division, Seattle, WA</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Curtis JR, Engelberg RA, Wenrich MD, Au DH. Communication about palliative care for patients with chronic obstructive pulmonary disease. J Palliat Care. 2005 Autumn;21(3):157-64. Review.</citation>
    <PMID>16334970</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinke LF, Slatore CG, Udris EM, Moss BR, Johnson EA, Au DH. The association of depression and preferences for life-sustaining treatments in veterans with chronic obstructive pulmonary disease. J Pain Symptom Manage. 2011 Feb;41(2):402-11. doi: 10.1016/j.jpainsymman.2010.05.012. Epub 2010 Dec 8.</citation>
    <PMID>21145201</PMID>
  </results_reference>
  <results_reference>
    <citation>Janssen DJ, Curtis JR, Au DH, Spruit MA, Downey L, Schols JM, Wouters EF, Engelberg RA. Patient-clinician communication about end-of-life care for Dutch and US patients with COPD. Eur Respir J. 2011 Aug;38(2):268-76. doi: 10.1183/09031936.00157710. Epub 2011 Jan 13.</citation>
    <PMID>21233263</PMID>
  </results_reference>
  <results_reference>
    <citation>Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD. 2012 Jun;9(3):251-8. doi: 10.3109/15412555.2011.650241. Epub 2012 Apr 12.</citation>
    <PMID>22497533</PMID>
  </results_reference>
  <results_reference>
    <citation>Cecere LM, Littman AJ, Slatore CG, Udris EM, Bryson CL, Boyko EJ, Pierson DJ, Au DH. Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD. 2011 Aug;8(4):275-84. doi: 10.3109/15412555.2011.586660. Epub 2011 Aug 2.</citation>
    <PMID>21809909</PMID>
  </results_reference>
  <results_reference>
    <citation>Au DH, Udris EM, Engelberg RA, Diehr PH, Bryson CL, Reinke LF, Curtis JR. A randomized trial to improve communication about end-of-life care among patients with COPD. Chest. 2012 Mar;141(3):726-735. doi: 10.1378/chest.11-0362. Epub 2011 Sep 22.</citation>
    <PMID>21940765</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinke LF, Slatore CG, Uman J, Udris EM, Moss BR, Engelberg RA, Au DH. Patient-clinician communication about end-of-life care topics: is anyone talking to patients with chronic obstructive pulmonary disease? J Palliat Med. 2011 Aug;14(8):923-8. doi: 10.1089/jpm.2010.0509. Epub 2011 Jun 1.</citation>
    <PMID>21631367</PMID>
  </results_reference>
  <results_reference>
    <citation>Reinke LF, Uman J, Udris EM, Moss BR, Au DH. Preferences for death and dying among veterans with chronic obstructive pulmonary disease. Am J Hosp Palliat Care. 2013 Dec;30(8):768-72. doi: 10.1177/1049909112471579. Epub 2013 Jan 8.</citation>
    <PMID>23298873</PMID>
  </results_reference>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2005</study_first_submitted>
  <study_first_submitted_qc>March 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2005</study_first_posted>
  <results_first_submitted>August 6, 2014</results_first_submitted>
  <results_first_submitted_qc>November 7, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 11, 2014</results_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Communication</keyword>
  <keyword>Palliative Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Bronchitis, Chronic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Patients gave written informed consent before enrollment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Intervention (Audit and Feedback)</title>
          <description>We solicited patients' preferences for health care communication and treatment in order to generate individualized summary reports of patient's preferences. These individualized summaries of patient's preferences regarding communication about end-of-life care and preferences for end-of-life care were used to activate patients, family members, and healthcare providers.</description>
        </group>
        <group group_id="P2">
          <title>Control (Usual Care)</title>
          <description>We solicited control patients' preferences but did not deliver study generated summary reports to patients, surrogates or providers.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="194"/>
                <participants group_id="P2" count="182"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="151"/>
                <participants group_id="P2" count="155"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrew/Loss to follow-up</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>42 clinicians were randomized to the intervention group. 50 clinicians were randomized to the control group. 376 patients were enrolled and assigned to their clinician's treatment group.</population>
      <group_list>
        <group group_id="B1">
          <title>Intervention</title>
          <description>Audit and feedback</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Usual care</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="194"/>
            <count group_id="B2" value="182"/>
            <count group_id="B3" value="376"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Patient age in years</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.4" spread="10.0"/>
                    <measurement group_id="B2" value="69.4" spread="10.0"/>
                    <measurement group_id="B3" value="69.4" spread="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <description>Patient gender reported as percent. *Total is incorrect due to auto-calculating field.</description>
          <units>percent</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97.9"/>
                    <measurement group_id="B2" value="96.2"/>
                    <measurement group_id="B3" value="194.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <description>Patient race reported as percent. *Total is incorrect due to auto-calculating field.</description>
          <units>percent</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85.3"/>
                    <measurement group_id="B2" value="87.0"/>
                    <measurement group_id="B3" value="172.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking Status</title>
          <description>Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.</description>
          <units>percent</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Never smoked</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.9"/>
                    <measurement group_id="B2" value="3.1"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Past smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.2"/>
                    <measurement group_id="B2" value="65.0"/>
                    <measurement group_id="B3" value="138.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Current smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.9"/>
                    <measurement group_id="B2" value="31.9"/>
                    <measurement group_id="B3" value="54.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Male Clinicians</title>
          <description>Clinician gender reported as percent. *Total is incorrect due to auto-calculating field.</description>
          <units>percent</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.0"/>
                    <measurement group_id="B2" value="44.0"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinician clinic</title>
          <description>Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.</description>
          <units>percent</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Geriatric</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.1"/>
                    <measurement group_id="B2" value="8.0"/>
                    <measurement group_id="B3" value="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Primary care/internal medicine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.3"/>
                    <measurement group_id="B2" value="68.0"/>
                    <measurement group_id="B3" value="132.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pulmonary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.6"/>
                    <measurement group_id="B2" value="24.0"/>
                    <measurement group_id="B3" value="52.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effect of Intervention on Quality of Patient Clinician Communication About End-of-Life Care(QOC) Scale</title>
        <description>The quality of end-of-life communication (QOC) score ranges between 0 and 100, with higher scores indicating better communication between patients and providers.</description>
        <time_frame>Measured at enrollment and 2 weeks after targeted clinic visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Audit and Feedback</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Intervention on Quality of Patient Clinician Communication About End-of-Life Care(QOC) Scale</title>
          <description>The quality of end-of-life communication (QOC) score ranges between 0 and 100, with higher scores indicating better communication between patients and providers.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="194"/>
                <count group_id="O2" value="182"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.3" lower_limit="19.9" upper_limit="26.8"/>
                    <measurement group_id="O2" value="19.2" lower_limit="15.9" upper_limit="22.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-visit</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.0" lower_limit="28.5" upper_limit="39.4"/>
                    <measurement group_id="O2" value="25.5" lower_limit="20.4" upper_limit="30.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Power calculation: With 60 providers in each group, maintaining the probability of a type I error of 0.05, power of 0.90, provider level mean QOC score of 54.5 and provider level standard deviation in QOC score of 12.0, the minimal detectable difference in QOC score would be 7.5.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <p_value_desc>No multiple comparisons, a priori threshold &lt; 0.05</p_value_desc>
            <method>GEE regression</method>
            <method_desc>Generalized estimating equations (GEE) regression, clustering for provider.</method_desc>
            <param_type>Difference between groups after adjust</param_type>
            <param_value>5.7</param_value>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effect of Intervention on Patient Reported Discussions About Treatment Preferences at Their Last Clinic Visit.</title>
        <description>We measured the difference between intervention and control group patients reporting having had a discussion with their clinician about treatment preferences at their last clinic visit.</description>
        <time_frame>Assessed 2 weeks after targeted clinic visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Audit and Feedback</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Intervention on Patient Reported Discussions About Treatment Preferences at Their Last Clinic Visit.</title>
          <description>We measured the difference between intervention and control group patients reporting having had a discussion with their clinician about treatment preferences at their last clinic visit.</description>
          <units>Proportion of participants reporting</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="194"/>
                <count group_id="O2" value="182"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.30" lower_limit="0.19" upper_limit="0.41"/>
                    <measurement group_id="O2" value="0.11" lower_limit="0.06" upper_limit="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>Audit and Feedback</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Usual care</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="194"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="182"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="194"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="182"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David H. Au, MD, MS</name_or_title>
      <organization>Department of Veterans Affairs, Health Services Research and Development</organization>
      <phone>206-764-2430</phone>
      <email>david.au@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

